BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Microbes, Inc. Extends Exchange Offer


6/11/2010 9:46:58 AM

THE WOODLANDS, Texas, June 10 /PRNewswire/ -- Microbes, Inc. today announced that it has extended its current offer to exchange shares of Common Stock for any and all of its outstanding Series 1, Series 2 and Series 3 Cumulative Preferred Stock until 12:00 midnight, New York City time, on Thursday, June 17, 2010. The exchange offer was scheduled to expire at 12:00 midnight, New York City time, on June 10, 2010.

The extension will provide holders of Preferred Stock additional time to determine whether to tender their shares of Preferred Stock in the exchange offer. Microbes is offering to exchange shares of Common Stock for shares of Preferred Stock, properly tendered and not withdrawn, at an exchange value of $2.00 per share of Common Stock. The rate at which the Company is offering to exchange shares of Common Stock is different for each series of Preferred Stock (the "Exchange Rate"). The Exchange Rate is determined as the quotient obtained by dividing the sum of (1) the stated value of the tendered shares of a particular series of Preferred Stock ($4.83 for the Series 1 Preferred Stock, $9.506 for the Series 2 Preferred Stock and $10.85 for the Series 3 Preferred Stock, respectively) plus(2) accrued and unpaid dividends on such shares to the date of acceptance by the Company in the offer by$2.00.

The exchange offer is being made solely by the Offer to Exchange, dated April 23, 2010, as amended or supplemented from time to time, and the related Letters of Transmittal. Holders of Preferred Stock are urged to read the Offer to Exchange and the related Letters of Transmittal, because they contain important information.

Microbes has developed and manufactures and markets a line of agricultural biofertilizer products through its wholly-owned subsidiary, Rhizogen, LLC. These products feature beneficial bacteria that enhance nutrient uptake by plants and increase crop health and yields. Microbes introduced the first organic, true granular, dry biological fertilizer. Microbes has also developed and marketed products for microbial-enhanced oil recovery by using naturally occurring bacteria in oil wells and oil producing reservoirs to enhance production and commercial value.

SOURCE Microbes, Inc.


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->